cancer drug price cap
Health
India Caps Cancer Drug Trade Margins at 30% of MRP
India caps trade margins on non-scheduled cancer drugs at 30% of MRP, aiming to cut prices by up to 70% and save patients ₹2,500 crore annually.
Health
India caps trade margins on non-scheduled cancer drugs at 30% of MRP, aiming to cut prices by up to 70% and save patients ₹2,500 crore annually.